Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy - Response

被引：0
|
作者：
Vansteenkiste, JF [1 ]
Colowick, AB
机构：
[1] Univ Hosp Gasthuisberg, Resp Oncol Unit Pulmonol, B-3000 Louvain, Belgium
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2003年 / 95卷 / 10期
关键词：
D O I：
10.1093/jnci/95.10.762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：762 / 763
页数：2
相关论文
共 50 条
  • [1] Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy
    VanAudenrode, M
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (10) : 761 - 762
  • [2] Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy
    Vansteenkiste, J
    Pirker, R
    Massuti, B
    Barata, F
    Font, A
    Fiegl, M
    Siena, S
    Gateley, J
    Tomita, D
    Colowick, AB
    Musil, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (16) : 1211 - 1220
  • [3] Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
    Smith, Robert E.
    Aapro, Matti S.
    Ludwig, Heinz
    Pinter, Tamas
    Smakal, Martin
    Ciuleanu, Tudor E.
    Chen, Li
    Lillie, Tom
    Glaspy, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1040 - 1050
  • [4] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA (DA) IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY
    Katakami, N.
    Nishiwaki, Y.
    Fujiwara, Y.
    Tsuboi, M.
    Takeda, K.
    Nakanishi, T.
    Ichinose, Y.
    Kawahara, M.
    Hotta, T.
    Saijo, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 277 - 278
  • [5] Melatonin in Patients with Cancer Receiving Chemotherapy: A Randomized, Double-blind, Placebo-controlled Trial
    Sookprasert, Aumkhae
    Johns, Nutjaree Pratheepawanit
    Phunmanee, Anakapong
    Pongthai, Parichart
    Cheawchanwattana, Areewan
    Johns, Jeff
    Konsil, Julraht
    Plaimee, Preeyaporn
    Porasuphatana, Supatra
    Jitpimolmard, Suthiphan
    ANTICANCER RESEARCH, 2014, 34 (12) : 7327 - 7337
  • [6] Results from a phase 3, randomized, double-blind, placebo-controlled study of darbepoetin alfa for the treatment of anemia in cancer patients not receiving chemotherapy or radiotherapy
    Glaspy, J. A.
    Smith, R. E.
    Aapro, M.
    Ludwig, H.
    Pinter, T.
    Smakal, M.
    Ciuleanu, T.
    Chen, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 136 - 136
  • [7] RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY
    Katsumata, N.
    Fujiwara, Y.
    Katakami, N.
    Nishiwaki, Y.
    Tsuboi, M.
    Takeda, K.
    Nakanishi, T.
    Ichinose, Y.
    Kawahara, Y.
    Hotta, T.
    Saijo, N.
    VOX SANGUINIS, 2009, 97 : 58 - 58
  • [8] Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
    Witzig, TE
    Silberstein, PT
    Loprinzi, CL
    Sloan, JA
    Novotny, PJ
    Mailliard, JA
    Rowland, KM
    Alberts, SR
    Krook, JE
    Levitt, R
    Morton, RF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2606 - 2617
  • [9] A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy
    Giles, FJ
    Rodriguez, R
    Weisdorf, D
    Wingard, JR
    Martin, PJ
    Fleming, TR
    Goldberg, SL
    Anaissie, EJ
    Bolwell, BJ
    Chao, NJ
    Shea, TC
    Brunvand, MM
    Vaughan, W
    Petersen, F
    Schubert, M
    Lazarus, HM
    Maziarz, RT
    Silverman, M
    Beveridge, RA
    Redman, R
    Pulliam, JG
    Devitt-Risse, P
    Fuchs, HJ
    Hurd, DD
    LEUKEMIA RESEARCH, 2004, 28 (06) : 559 - 565
  • [10] Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
    Littlewood, TJ
    Bajetta, E
    Nortier, JWR
    Vercammen, E
    Rapoport, B
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) : 2865 - 2874
12345